GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH
Roswell Park Cancer Institute
Cancer Research UK
Immatics Biotechnologies GmbH
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center